Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RETA | AZN | AMGN | GILD | BMY |
| Company | Reata Pharma | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 172.34 | 168.75 | 363.04 | 129.66 | 57.90 |
| High | 172.46 | 170.47 | 363.29 | 131.67 | 59.44 |
| Low | 172.32 | 168.11 | 355.73 | 127.93 | 57.54 |
| Latest | 172.36 | 169.47 | 360.45 | 131.40 | 59.34 |
| Change | +0.04 | -2.14 | -2.94 | +1.57 | +1.76 |
| % Change | +0.02% | -1.25% | -0.81% | +1.21% | +3.06% |
| Volume | 1,988,500 | 4,666,100 | 2,057,600 | 5,105,500 | 12,024,700 |
| 20-Day Average Volume | 810,510 | 2,460,345 | 2,842,480 | 8,438,785 | 13,233,105 |
| Previous Close | 172.32 | 171.61 | 363.39 | 129.83 | 57.58 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 170.84 | 182.69 | 356.76 | 128.04 | 56.73 |
| 20-Day Raw Stochastic | 97.36% | 4.81% | 64.08% | 58.74% | 98.33% |
| 20-Day Relative Strength | 81.56 | 39.59 | 55.43 | 51.93 | 56.48 |
| Weighted Alpha | +177.60 | +9.96 | +21.27 | +16.03 | +25.02 |
| Today's Opinion | 100% Buy | 88% Sell | 72% Buy | 24% Sell | 40% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 72% Buy | 56% Sell | 16% Buy |
| Last Month's Opinion | 100% Buy | 40% Sell | 8% Sell | 40% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/18/23 | -10.88% since 07/06/26 | -1.63% since 07/06/26 | +1.38% since 07/06/26 | +4.66% since 07/06/26 |
| Low | 171.96 on 09/19/23 | 168.11 on 07/13/26 | 355.73 on 07/13/26 | 127.93 on 07/13/26 | 56.94 on 07/10/26 |
| High | 172.46 on 09/25/23 | 193.79 on 07/07/26 | 375.25 on 07/07/26 | 137.70 on 07/08/26 | 59.44 on 07/13/26 |
| 1-Month | |||||
| %Chg | +1.99% since 08/25/23 | -5.19% since 06/12/26 | +1.48% since 06/12/26 | +4.63% since 06/12/26 | +3.87% since 06/12/26 |
| Low | 168.67 on 09/05/23 | 168.11 on 07/13/26 | 334.05 on 06/18/26 | 122.43 on 06/18/26 | 53.44 on 06/18/26 |
| High | 172.46 on 09/25/23 | 196.41 on 07/02/26 | 375.25 on 07/07/26 | 137.70 on 07/08/26 | 59.44 on 07/13/26 |
| 3-Month | |||||
| %Chg | +83.77% since 06/23/23 | -16.20% since 04/13/26 | +3.04% since 04/13/26 | -5.49% since 04/13/26 | +2.20% since 04/13/26 |
| Low | 88.80 on 06/27/23 | 168.11 on 07/13/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 172.46 on 09/25/23 | 205.30 on 04/17/26 | 375.25 on 07/07/26 | 141.40 on 04/14/26 | 60.78 on 04/30/26 |
| 6-Month | |||||
| %Chg | +101.14% since 03/24/23 | -10.34% since 01/13/26 | +11.15% since 01/13/26 | +7.92% since 01/13/26 | +6.12% since 01/13/26 |
| Low | 76.54 on 05/10/23 | 168.11 on 07/13/26 | 320.52 on 05/05/26 | 120.94 on 01/15/26 | 53.44 on 06/18/26 |
| High | 172.46 on 09/25/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,575,535 | 266,151,328 | 196,124,496 | 161,193,024 | 117,582,448 |
| Shares Outstanding, K | 38,150 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 2,220,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -311,900,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 22,750,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | 193,000,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.42 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/08/23 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 11/14/23 | 07/27/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.28 | 16.45 | 16.11 | 9.77 |